Evidence map›Paper›PMID 31741142›Full record

ReviewCurrent psychiatry reports2019

Understanding Chronic Aggression and Its Treatment in Children and Adolescents.

Selena R Magalotti, Mandy Neudecker, Solomon G Zaraa, Molly K McVoy

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Aggressive behaviour among children and adolescents at a public outpatient psychiatric facility.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Selena R MagalottiDepartment of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Mandy NeudeckerDepartment of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Solomon G ZaraaDepartment of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Molly K McVoyDepartment of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. molly.mcvoy@uhhospitals.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewYouth aggression is common and has a significant burden on individuals, families, and society. However, its treatment is often a challenge for clinicians. Thus, this review will examine the current understanding of youth aggression, conceptualize aggression as a symptom rather than its own disorder, and provide an overview of treatment strategies. RECENT

findingsYouth aggression is associated with complex genetic, neurobiological, and environmental risks. Prevention strategies are of the utmost importance for at-risk families and youth. Psychosocial interventions are the first line treatment. But if not fully effective, then pharmacologic interventions-including psychostimulants, alpha-2 agonists, atomoxetine, and risperidone-have shown benefits. Other medications, such as SSRIs, can be useful in certain scenarios. It is important to conceptualize youth aggression as being a trans-diagnostic symptom in psychopathology. Determining the underlying cause of aggression will help to guide treatment.

Indexed as

AdolescentAggressionAntipsychotic AgentsAttention Deficit and Disruptive Behavior DisordersAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildHumansRisperidoneAntipsychotic AgentsCentral Nervous System StimulantsRisperidoneADHDAggressionAntipsychoticConductODDPediatricStimulantTreatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.